↓ Skip to main content

AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer models

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, May 2014
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
34 Mendeley